Gen Z still wants ESG April 1, 2026 There's still a case for purpose over profit, not least because our Gen Z business successors are demanding it, writes Natasha Frangos.
London City Lionesses CEO Martin Semmens: ‘We want to be sustainable’ April 1, 2026 London City Lionesses may have made their presence felt in the Women’s Super League by spending big on star signings such as Grace Geyoro, but Michele Kang’s riches are going on much more besides. It should probably come as no surprise that Kang applies the same attention to detail that made her a billionaire in [...]
Monzo and Revolut take banking battle to the playground April 1, 2026 Banks are turning their attention to the younger generation and in this week’s column Samuel Norman takes a look at the money to be made with Gen Alpha. The Tooth Fairy is losing her magic touch. After centuries of cultural dominance in the under-the-pillow money market, the primary dealer of calcium-for-cash faces a hostile takeover. [...]
Options Technology Completes Acquisition of Crossvale, Expanding Private Cloud and AI Modernization Capabilities March 31, 2026 Options Technology (Options), the leading provider of institutional-grade infrastructure, market data, and managed services for global financial services, today announced the successful completion of its acquisition of Crossvale, a US-headquartered leader in application and platform modernization. The completed acquisition strengthens Options’ ability to help financial services firms modernize legacy environments, reduce technology debt, and accelerate [...]
AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial March 31, 2026 Early biomarker and safety data show encouraging signals with plans to present additional data in 2H 2026 AviadoBio secures strategic investment from The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) through their Treat FTD Fund to support ASPIRE-FTD Trial AviadoBio regains full rights to AVB-101 gene therapy program
AngloGold Ashanti Holdings plc Announces Capped Cash Tender Offers for Part of Its 3.375% Notes Due 2028, 3.750% Notes Due 2030 and 6.500% Notes Due 2040 March 30, 2026 AngloGold Ashanti Holdings plc (the “Offeror”), a company incorporated under the laws of the Isle of Man, announces today the offers to purchase for cash the outstanding series of its (i) 3.375% notes due 2028 (the “2028 Notes”), (ii) 3.750% notes due 2030 (the “2030 Notes”) and (iii) 6.500% notes due 2040 (the “2040 Notes” [...]
Whisky investment: Liquidity is the real test of a collectible March 30, 2026 Geraldine Napier-Payne, Head of Portfolio Management, LGT Wealth Management One reason investors are drawn to collectibles is that the entry story is so compelling. Whisky, fine wine, art, and watches – along with more modern phenomena like trading cards and sneakers – can offer the potential for price appreciation. They also deliver something else many [...]
US gearing up for ‘weeks of ground operations’ in Iran March 29, 2026 The US military is reportedly gearing up for “weeks of ground operations” in Iran in a move that will destroy optimism garnered over the last week that a peace deal could be on the horizon. Sources at the Pentagon have told the Washington Post that the potential operations would not amount to a full invasion, [...]
Premier League +, VPN piracy and lessons from Norway and France March 28, 2026 The Premier League is built on its precious media rights but will its new streaming service be susceptible to the piracy that just scuppered a similar service in Norway? In less than five months’ time the Premier League will take one of the most significant steps in its history when it launches its own direct-to-consumer [...]
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth March 27, 2026 Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD [...]